INBRAIN Neuroelectronics the innovative start-up that Nanomedicine Lab members co-founded with Professor Jose Garido (ICN2) and Dr Anton Guimera (CNM), dedicated to the development of Brain-Computer Interface Therapeutics (BCI-Tx) to improve management of various neurological conditions, has announced a Series B $50 million financing round.

Bloomberg TV, a global news network focused on live financial market coverage, business news, and economic insights, catering primarily to finance professionals and investors, announced the milestone funding round. Together with the world’s first-in-human clinical trial of any type of graphene-based medical device this represents a breakthrough for INBRAIN and the efforts to translate graphene into medicine.

Watch INBRAIN CEO Carolina Aguilar interviewed by Bloomberg TV.